These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29288038)

  • 21. BRG1 is a prognostic marker and potential therapeutic target in human breast cancer.
    Bai J; Mei P; Zhang C; Chen F; Li C; Pan Z; Liu H; Zheng J
    PLoS One; 2013; 8(3):e59772. PubMed ID: 23533649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BRG1 expression in prostate carcinoma by application of tissue microarray].
    Li Y; Shi QL; Jin XZ; Meng K; Zhou XJ; Sun LP
    Zhonghua Nan Ke Xue; 2006 Jul; 12(7):629-32. PubMed ID: 16894943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRG1 promotes VEGF-A expression and angiogenesis in human colorectal cancer cells.
    Lan J; Li H; Luo X; Hu J; Wang G
    Exp Cell Res; 2017 Nov; 360(2):236-242. PubMed ID: 28899659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
    Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
    Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer.
    Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P
    World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of BRG1 silencing in primary cancers.
    Marquez-Vilendrer SB; Thompson K; Lu L; Reisman D
    Oncotarget; 2016 Aug; 7(35):56153-56169. PubMed ID: 27486753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression.
    Yoshikawa T; Fukuda A; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Kawada K; Takaishi S; Seno H
    Cancer Sci; 2022 Oct; 113(10):3417-3427. PubMed ID: 35924439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
    Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
    Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
    Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brg1 inhibits E-cadherin expression in lung epithelial cells and disrupts epithelial integrity.
    Wang T; Zou W; Niu C; Ding F; Wang Y; Cai S; Zhu H; Tian D; Dai J; Liu E; Lu Q; Fu Z; Zou L
    J Mol Med (Berl); 2017 Oct; 95(10):1117-1126. PubMed ID: 28801844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 Expression is a prognostic factor in colorectal cancer.
    Guo HQ; Huang GL; Liu OF; Liu YY; Yao ZH; Yao SN; Zhao Y; Liu T; Pu XX; Lin TY; Yang SJ
    Int J Biol Markers; 2012 Oct; 27(3):e212-8. PubMed ID: 23015401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
    Zhu X; Sun L; Lan J; Xu L; Zhang M; Luo X; Gong J; Wang G; Yuan X; Hu J; Wang J
    Oncotarget; 2016 Jun; 7(24):36501-36509. PubMed ID: 27145366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.
    Lin S; Jiang T; Ye L; Han Z; Liu Y; Liu C; Yuan C; Zhao S; Chen J; Wang J; Tang H; Lu S; Yang L; Wang X; Yan D; Peng Z; Fan J
    Oncotarget; 2016 Dec; 7(52):86051-86063. PubMed ID: 27852072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
    Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
    Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
    Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
    World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.